Skip to Content


In the US, Zortress (everolimus systemic) is a member of the following drug classes: mTOR inhibitors, selective immunosuppressants and is used to treat Brain Tumor, Neuroendocrine Carcinoma and Organ Transplant - Rejection Prophylaxis.

US matches:

Ingredient matches for Zortress


Everolimus is reported as an ingredient of Zortress in the following countries:

  • United States

International Drug Name Search

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.